Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility

Eighteen months after Novo Nordisk purchased a plant in the | Eighteen months after Novo Nordisk purchased a plant in the Czech Republic from Novavax, the Danish drugmaker said it is set to kick off the manufacturing of ingredients for next-generation diabetes and obesity drugs at the facility. The company also announced locally that it will invest $29 million in its plant in China.